Read More
Many factors contribute to this large gap. The U.S. relies more on newer, more expensive forms of insulin, and the regulatory environment in some other countries helps keep prices lower. Countries with single-payer systems, like the United Kingdom and Canada, can use their negotiating power to keep prices down too.
The current situation is a far cry from what the inventors of insulin envisioned over a century ago. After selling their patent for the drug for $1, one co-inventor declared “insulin belongs to the world.” Even with Eli Lilly’s recent move, the drug will remain hard to reach for many Americans.
Start your day with the biggest stories and exclusive reporting from The Messenger Morning, our weekday newsletter.
By signing up, you agree to our privacy policy and terms of use.
Sign Up.
Thanks for Signing up!
You are now signed up for our newsletter.
You are now signed up for our newsletter.
More News.
- What Ramadan really means to me — and nearly 2 billion MuslimsGrid
- France protests, explained in five words: ‘Life begins when work ends’Grid
- Medical residents nationwide are unionizing. What does that mean for the future of healthcare?Grid
- Ramadan fashion hits the runways. Muslim women say it’s been a long time coming.Grid
- Who is Shou Zi Chew – the TikTok CEO doing all he can to keep his app going in the U.S.?Grid
- The SVB collapse has made deposits more valuable than ever — and banks will have to compete for themGrid
- Ukraine War in Data: 74,500 war crimes cases — and countingGrid
- Can China really play a role in ending the war in Ukraine?Grid
- ‘No Dumb Questions’: What is Section 230?Grid
- Trump steers allies and opponents on the right to a new enemy: Manhattan District Attorney Alvin BraggGrid
- World in Photos: In France, no-confidence vote and fresh protestsGrid
- Bad Takes, Episode 32: The lesson elites should have learned from IraqGrid